(2,4,5-trichlorophenoxy)acetic acid decreases expression ISO RGD:62186 6480464 2 more ... CTD PMID:18579281 1,1-dichloroethene increases expression ISO RGD:62186 6480464 vinylidene chloride results in increased expression of PFKP mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:62186 6480464 ethylene dichloride results in decreased expression of PFKP mRNA CTD PMID:28960355 1,2-dimethylhydrazine affects expression ISO RGD:62186 6480464 1, 2-Dimethylhydrazine affects the expression of PFKP mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PFKP mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PFKP mRNA CTD PMID:12075121 17beta-estradiol increases expression ISO RGD:731015 6480464 Estradiol results in increased expression of PFKP mRNA CTD PMID:31614463 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:62186 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:62186 6480464 2 more ... CTD PMID:30294300 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:731015 6480464 2 more ... CTD PMID:31675489 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:62186 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:62186 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PFKP gene] CTD PMID:20819909 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731015 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of PFKP mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PFKP mRNA CTD PMID:20959002 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731015 6480464 Tetrachlorodibenzodioxin results in increased expression of PFKP mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:62186 6480464 Tetrachlorodibenzodioxin affects the expression of PFKP mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:62186 6480464 Tetrachlorodibenzodioxin results in decreased expression of PFKP mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62186 6480464 Tetrachlorodibenzodioxin results in increased expression of PFKP mRNA CTD PMID:20819909 2,4,6-tribromophenol decreases expression ISO RGD:731015 6480464 2 more ... CTD PMID:31675489 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:62186 6480464 Glucosamine results in increased expression of PFKP mRNA CTD PMID:17178593 2-hydroxypropanoic acid decreases expression ISO RGD:731015 6480464 Lactic Acid results in decreased expression of PFKP mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:731015 6480464 beta-methylcholine affects the expression of PFKP mRNA CTD PMID:21179406 3,3',5-triiodo-L-thyronine increases expression ISO RGD:731015 6480464 Triiodothyronine results in increased expression of PFKP mRNA CTD PMID:15507505 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of PFKP mRNA CTD PMID:28087314 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of PFKP mRNA CTD PMID:28522335 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of PFKP protein CTD PMID:34915118 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:731015 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PFKP mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PFKP mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of PFKP mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:731015 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PFKP protein CTD PMID:34186270 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PFKP mRNA CTD PMID:36041667 acetamide increases expression EXP 6480464 acetamide results in increased expression of PFKP mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:731015 6480464 Acrylamide results in decreased expression of PFKP mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:731015 6480464 Aflatoxin B1 affects the expression of PFKP protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:731015 6480464 Aflatoxin B1 results in increased methylation of PFKP intron CTD PMID:30157460 aflatoxin B1 increases expression ISO RGD:731015 6480464 Aflatoxin B1 results in increased expression of PFKP mRNA CTD PMID:22100608 more ... aflatoxin B1 decreases expression ISO RGD:62186 6480464 Aflatoxin B1 results in decreased expression of PFKP mRNA CTD PMID:19770486 aldehydo-D-glucosamine increases expression ISO RGD:62186 6480464 Glucosamine results in increased expression of PFKP mRNA CTD PMID:17178593 aldrin decreases expression ISO RGD:62186 6480464 Aldrin results in decreased expression of PFKP mRNA CTD PMID:18579281 all-trans-retinoic acid decreases expression ISO RGD:62186 6480464 Tretinoin results in decreased expression of PFKP mRNA CTD PMID:16604517 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PFKP mRNA CTD PMID:16483693 antimycin A increases expression ISO RGD:731015 6480464 Antimycin A results in increased expression of PFKP mRNA CTD PMID:34642769 aristolochic acids increases expression EXP 6480464 Aristolochic Acids results in increased expression of PFKP mRNA CTD PMID:19717638 Aroclor 1254 decreases expression ISO RGD:62186 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of PFKP mRNA CTD PMID:23650126 arsenous acid decreases expression ISO RGD:731015 6480464 Arsenic Trioxide results in decreased expression of PFKP protein CTD PMID:25419056 Azaspiracid increases expression ISO RGD:731015 6480464 azaspiracid results in increased expression of PFKP mRNA CTD PMID:28939011 benzo[a]pyrene increases expression ISO RGD:731015 6480464 Benzo(a)pyrene results in increased expression of PFKP mRNA CTD PMID:20106945 , PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:731015 6480464 Benzo(a)pyrene results in increased methylation of PFKP promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:62186 6480464 Benzo(a)pyrene results in decreased expression of PFKP mRNA CTD PMID:19770486 beta-D-glucosamine increases expression ISO RGD:62186 6480464 Glucosamine results in increased expression of PFKP mRNA CTD PMID:17178593 bis(2-ethylhexyl) phthalate increases expression ISO RGD:731015 6480464 Diethylhexyl Phthalate results in increased expression of PFKP mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:731015 6480464 bisphenol A results in decreased expression of PFKP mRNA, bisphenol A results in decreased expression of PFKP protein CTD PMID:25047013 , PMID:31675489 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PFKP mRNA CTD PMID:36041667 bisphenol A multiple interactions ISO RGD:731015 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PFKP mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PFKP mRNA CTD PMID:30816183 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PFKP mRNA CTD PMID:12075121 more ... bisphenol F multiple interactions ISO RGD:731015 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PFKP mRNA CTD PMID:28628672 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PFKP mRNA CTD PMID:36041667 butan-1-ol multiple interactions ISO RGD:731015 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PFKP mRNA CTD PMID:29432896 butyric acid multiple interactions ISO RGD:62186 6480464 Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA] CTD PMID:29751049 cadmium atom multiple interactions EXP 6480464 [cadmium acetate results in increased abundance of Cadmium] which results in decreased expression of PFKP mRNA, puerarin inhibits the reaction [[cadmium acetate results in increased abundance of Cadmium] which results in decreased expression of PFKP mRNA] CTD PMID:33404196 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PFKP mRNA CTD PMID:33453195 cadmium sulfate increases expression ISO RGD:62186 6480464 cadmium sulfate results in increased expression of PFKP mRNA CTD PMID:19274763 caffeine decreases phosphorylation ISO RGD:731015 6480464 Caffeine results in decreased phosphorylation of PFKP protein CTD PMID:35688186 chloroethene decreases expression ISO RGD:62186 6480464 Vinyl Chloride results in decreased expression of PFKP mRNA CTD PMID:18579281 chloropicrin increases expression ISO RGD:731015 6480464 chloropicrin results in increased expression of PFKP mRNA CTD PMID:26352163 chlorpyrifos increases expression ISO RGD:62186 6480464 Chlorpyrifos results in increased expression of PFKP mRNA CTD PMID:32715474 choline multiple interactions ISO RGD:62186 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PFKP mRNA CTD PMID:20938992 cisplatin affects response to substance ISO RGD:731015 6480464 PFKP protein affects the susceptibility to Cisplatin CTD PMID:16217747 clofibrate increases expression ISO RGD:62186 6480464 Clofibrate results in increased expression of PFKP mRNA CTD PMID:17585979 clotrimazole affects localization ISO RGD:62186 6480464 Clotrimazole affects the localization of PFKP protein CTD PMID:12126931 clozapine increases expression EXP 6480464 Clozapine results in increased expression of PFKP mRNA CTD PMID:15860345 copper atom multiple interactions ISO RGD:62186 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PFKP mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:62186 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PFKP mRNA CTD PMID:15467011 copper(II) chloride increases expression ISO RGD:731015 6480464 cupric chloride results in increased expression of PFKP mRNA CTD PMID:34921933 copper(II) sulfate increases expression ISO RGD:731015 6480464 Copper Sulfate results in increased expression of PFKP mRNA CTD PMID:19549813 copper(II) sulfate decreases expression ISO RGD:62186 6480464 Copper Sulfate results in decreased expression of PFKP mRNA CTD PMID:18579281 corticosterone multiple interactions ISO RGD:62186 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA more ... CTD PMID:29751049 Cuprizon multiple interactions ISO RGD:731015 6480464 [Cuprizone co-treated with Haloperidol] results in increased expression of PFKP protein CTD PMID:34122009 cyclosporin A increases expression ISO RGD:731015 6480464 Cyclosporine results in increased expression of PFKP mRNA CTD PMID:20106945 , PMID:25562108 cytarabine decreases expression ISO RGD:731015 6480464 Cytarabine results in decreased expression of PFKP mRNA CTD PMID:21198554 deguelin increases expression ISO RGD:731015 6480464 deguelin results in increased expression of PFKP mRNA CTD PMID:34642769 dexamethasone multiple interactions ISO RGD:731015 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PFKP mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PFKP mRNA CTD PMID:28628672 diarsenic trioxide decreases expression ISO RGD:731015 6480464 Arsenic Trioxide results in decreased expression of PFKP protein CTD PMID:25419056 diazinon increases methylation ISO RGD:731015 6480464 Diazinon results in increased methylation of PFKP gene CTD PMID:22964155 dibutyl phthalate increases expression ISO RGD:62186 6480464 Dibutyl Phthalate results in increased expression of PFKP mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PFKP mRNA CTD PMID:17379624 , PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PFKP mRNA CTD PMID:21266533 Diisodecyl phthalate increases expression ISO RGD:62186 6480464 diisodecyl phthalate results in increased expression of PFKP mRNA CTD PMID:25270620 dioxygen increases expression ISO RGD:731015 6480464 Oxygen deficiency results in increased expression of PFKP mRNA CTD PMID:20042640 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PFKP mRNA CTD PMID:33729688 dioxygen increases expression ISO RGD:62186 6480464 Oxygen deficiency results in increased expression of PFKP mRNA CTD PMID:20880076 dioxygen affects expression ISO RGD:62186 6480464 Oxygen deficiency affects the expression of PFKP mRNA CTD PMID:17193925 dorsomorphin multiple interactions ISO RGD:731015 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of PFKP mRNA CTD PMID:19915844 doxorubicin increases expression ISO RGD:731015 6480464 Doxorubicin results in increased expression of PFKP mRNA CTD PMID:29803840 doxorubicin multiple interactions EXP 6480464 Razoxane inhibits the reaction [Doxorubicin results in increased expression of PFKP mRNA] CTD PMID:19915844 duvoglustat multiple interactions ISO RGD:62186 6480464 [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of PFKP protein] CTD PMID:25446853 endosulfan multiple interactions ISO RGD:731015 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of PFKP mRNA CTD PMID:26159488 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of PFKP mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:731015 6480464 entinostat results in increased expression of PFKP mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions ISO RGD:731015 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA CTD PMID:27188386 ethanol affects splicing ISO RGD:62186 6480464 Ethanol affects the splicing of PFKP mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:731015 6480464 Ethyl Methanesulfonate results in decreased expression of PFKP mRNA CTD PMID:23649840 fenpyroximate increases expression ISO RGD:731015 6480464 fenpyroximate results in increased expression of PFKP mRNA CTD PMID:34642769 folic acid multiple interactions ISO RGD:62186 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PFKP mRNA CTD PMID:20938992 formaldehyde decreases expression ISO RGD:731015 6480464 Formaldehyde results in decreased expression of PFKP mRNA CTD PMID:23649840 fulvestrant increases methylation ISO RGD:731015 6480464 Fulvestrant results in increased methylation of PFKP gene CTD PMID:31601247 genistein increases expression EXP 6480464 Genistein results in increased expression of PFKP mRNA CTD PMID:12075121 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PFKP mRNA CTD PMID:22061828 , PMID:33387578 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of PFKP mRNA CTD PMID:15860345 haloperidol multiple interactions ISO RGD:731015 6480464 [Cuprizone co-treated with Haloperidol] results in increased expression of PFKP protein CTD PMID:34122009 hydrogen sulfide decreases expression ISO RGD:62186 6480464 Hydrogen Sulfide results in decreased expression of PFKP protein CTD PMID:29932956 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of PFKP mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:731015 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PFKP mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PFKP mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:62186 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PFKP mRNA CTD PMID:36331819 ivermectin decreases expression ISO RGD:731015 6480464 Ivermectin results in decreased expression of PFKP protein CTD PMID:32959892 josamycin decreases response to substance ISO RGD:731015 6480464 PFKP protein results in decreased susceptibility to Josamycin CTD PMID:31915244 L-methionine multiple interactions ISO RGD:62186 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PFKP mRNA CTD PMID:20938992 lipopolysaccharide multiple interactions ISO RGD:731015 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of PFKP mRNA CTD PMID:35877022 menadione decreases expression ISO RGD:62186 6480464 Vitamin K 3 results in decreased expression of PFKP mRNA CTD PMID:25270620 mercury dibromide increases expression ISO RGD:731015 6480464 mercuric bromide results in increased expression of PFKP mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:731015 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA CTD PMID:27188386 methyl methanesulfonate decreases expression ISO RGD:731015 6480464 Methyl Methanesulfonate results in decreased expression of PFKP mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:731015 6480464 methylmercuric chloride results in decreased expression of PFKP mRNA CTD PMID:23179753 , PMID:27188386 methylmercury chloride increases expression ISO RGD:731015 6480464 methylmercuric chloride results in increased expression of PFKP mRNA CTD PMID:28001369 mithramycin decreases expression ISO RGD:62186 6480464 Plicamycin results in decreased expression of PFKP mRNA CTD PMID:34087332 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:62186 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PFKP mRNA] CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:62186 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PFKP mRNA CTD PMID:25566086 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:62186 6480464 [IL4 protein co-treated with 1-Methyl-4-phenylpyridinium] results in increased expression of PFKP mRNA CTD PMID:32606391 N-methyl-N-nitrosourea decreases expression ISO RGD:62186 6480464 Methylnitrosourea results in decreased expression of PFKP mRNA CTD PMID:25270620 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PFKP mRNA CTD PMID:20360939 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of PFKP mRNA CTD PMID:25380136 N-Nitrosopyrrolidine increases expression ISO RGD:731015 6480464 N-Nitrosopyrrolidine results in increased expression of PFKP mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:731015 6480464 Nickel results in increased expression of PFKP mRNA CTD PMID:24768652 , PMID:25583101 O-methyleugenol increases expression ISO RGD:731015 6480464 methyleugenol results in increased expression of PFKP mRNA CTD PMID:32234424 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of PFKP mRNA CTD PMID:19717638 ochratoxin A increases expression ISO RGD:731015 6480464 ochratoxin A results in increased expression of PFKP protein CTD PMID:32835834 oxaliplatin decreases expression ISO RGD:731015 6480464 oxaliplatin results in decreased expression of PFKP mRNA CTD PMID:17762391 panobinostat increases expression ISO RGD:731015 6480464 panobinostat results in increased expression of PFKP mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:731015 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:62186 6480464 Acetaminophen affects the expression of PFKP mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PFKP mRNA CTD PMID:15084756 , PMID:33387578 paraquat decreases expression ISO RGD:62186 6480464 Paraquat results in decreased expression of PFKP mRNA CTD PMID:21371552 PCB138 multiple interactions ISO RGD:62186 6480464 [2 more ... CTD PMID:25510870 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:62186 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PFKP mRNA CTD PMID:36331819 permethrin multiple interactions ISO RGD:62186 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA more ... CTD PMID:29751049 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PFKP mRNA CTD PMID:20360939 phenylmercury acetate increases expression ISO RGD:731015 6480464 Phenylmercuric Acetate results in increased expression of PFKP mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:731015 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA CTD PMID:27188386 picrotoxin decreases expression EXP 6480464 Picrotoxin results in decreased expression of PFKP mRNA CTD PMID:15170462 pirinixic acid decreases expression ISO RGD:62186 6480464 pirinixic acid results in decreased expression of PFKP mRNA CTD PMID:17426115 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of PFKP mRNA CTD PMID:19162173 pirinixic acid increases expression ISO RGD:62186 6480464 pirinixic acid results in increased expression of PFKP mRNA CTD PMID:20813756 puerarin multiple interactions EXP 6480464 puerarin inhibits the reaction [[cadmium acetate results in increased abundance of Cadmium] which results in decreased expression of PFKP mRNA] CTD PMID:33404196 Pyridostigmine bromide multiple interactions ISO RGD:62186 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA more ... CTD PMID:29751049 pyrimidifen increases expression ISO RGD:731015 6480464 pyrimidifen results in increased expression of PFKP mRNA CTD PMID:34642769 quercetin increases expression ISO RGD:731015 6480464 Quercetin results in increased expression of PFKP mRNA CTD PMID:19729006 , PMID:21632981 rac-lactic acid decreases expression ISO RGD:731015 6480464 Lactic Acid results in decreased expression of PFKP mRNA CTD PMID:30851411 razoxane multiple interactions EXP 6480464 Razoxane inhibits the reaction [Doxorubicin results in increased expression of PFKP mRNA] CTD PMID:19915844 resveratrol increases expression ISO RGD:62186 6480464 resveratrol results in increased expression of PFKP protein CTD PMID:25505154 rotenone increases expression ISO RGD:731015 6480464 Rotenone results in increased expression of PFKP mRNA CTD PMID:29955902 , PMID:34642769 rotenone multiple interactions ISO RGD:62186 6480464 Rotenone inhibits the reaction [[lipopolysaccharide, E. coli O26-B6 co-treated with IFNG protein] results in increased expression of PFKP mRNA] CTD PMID:30686998 sarin decreases expression ISO RGD:731015 6480464 Sarin results in decreased expression of PFKP mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:731015 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:731015 6480464 Silicon Dioxide analog results in increased expression of PFKP mRNA CTD PMID:25895662 sodium fluoride increases expression ISO RGD:62186 6480464 Sodium Fluoride results in increased expression of PFKP protein CTD PMID:28918527 streptozocin multiple interactions ISO RGD:62186 6480464 [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of PFKP protein], [Dietary Fats co-treated with Streptozocin] results in decreased expression of PFKP protein CTD PMID:25446853 sunitinib increases expression ISO RGD:731015 6480464 Sunitinib results in increased expression of PFKP mRNA CTD PMID:31533062 tebufenpyrad increases expression ISO RGD:731015 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of PFKP mRNA CTD PMID:34642769 tert-butyl hydroperoxide increases expression ISO RGD:62186 6480464 tert-Butylhydroperoxide results in increased expression of PFKP mRNA CTD PMID:15003993 tetrachloroethene increases expression ISO RGD:62186 6480464 Tetrachloroethylene results in increased expression of PFKP mRNA CTD PMID:28973375 tetrachloromethane affects expression ISO RGD:62186 6480464 Carbon Tetrachloride affects the expression of PFKP mRNA CTD PMID:17484886 thapsigargin decreases expression ISO RGD:731015 6480464 Thapsigargin results in decreased expression of PFKP mRNA CTD PMID:22378314 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of PFKP protein CTD PMID:35544339 thimerosal decreases expression ISO RGD:731015 6480464 Thimerosal results in decreased expression of PFKP mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PFKP mRNA CTD PMID:34492290 trichostatin A increases expression ISO RGD:731015 6480464 trichostatin A results in increased expression of PFKP mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:731015 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:62186 6480464 trimellitic anhydride results in increased expression of PFKP mRNA CTD PMID:19042947 Triptolide increases expression EXP 6480464 triptolide results in increased expression of PFKP protein CTD PMID:32519852 Triptolide decreases expression ISO RGD:62186 6480464 triptolide results in decreased expression of PFKP mRNA more ... CTD PMID:34087332 tris(2-butoxyethyl) phosphate affects expression ISO RGD:731015 6480464 tris(2-butoxyethyl) phosphate affects the expression of PFKP mRNA CTD PMID:29024780 tunicamycin decreases expression ISO RGD:731015 6480464 Tunicamycin results in decreased expression of PFKP mRNA CTD PMID:22378314 valproic acid increases expression ISO RGD:62186 6480464 Valproic Acid results in increased expression of PFKP mRNA CTD PMID:19136453 more ... valproic acid multiple interactions ISO RGD:731015 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:731015 6480464 Valproic Acid results in increased expression of PFKP mRNA CTD PMID:23179753 more ... valproic acid increases methylation ISO RGD:731015 6480464 Valproic Acid results in increased methylation of PFKP gene CTD PMID:29154799 valproic acid affects expression ISO RGD:731015 6480464 Valproic Acid affects the expression of PFKP mRNA CTD PMID:25979313 vanadium atom decreases expression ISO RGD:731015 6480464 Vanadium results in decreased expression of PFKP mRNA CTD PMID:19000753 vanadium(0) decreases expression ISO RGD:731015 6480464 Vanadium results in decreased expression of PFKP mRNA CTD PMID:19000753 vitamin E increases expression ISO RGD:731015 6480464 Vitamin E results in increased expression of PFKP mRNA CTD PMID:19244175 vorinostat multiple interactions ISO RGD:731015 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:731015 6480464 vorinostat results in increased expression of PFKP mRNA CTD PMID:26272509
